Inventive Infusion Solutions, LP
FDA inspection history across 2 sites, 2018 to 2021
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2018: one Form 483; 2021: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2018One Form 483, at San Antonio, Texas.
- 2021One warning letter, at Texas.
Cited most
Across all Inventive Infusion Solutions observations on file
- 21 CFR 211.113Control of microbiological contamination4
- 21 CFR 211.42Design and construction features2
- 21 CFR 211.167Special testing requirements1
- 21 CFR 211.28Personnel responsibilities1
The complete Inventive Infusion Solutions file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Texas
One warning letter · 2021
Latest: Warning letter, Jul 15, 2021 →San Antonio, Texas
One Form 483 · 2018 · 8 observations
Latest: Form 483, Aug 31, 2018 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2021-07-15 | Warning letter Warning letter | Texas | — | $99 |
| 2018-08-31 | 483 Form 483 | San Antonio, Texas | 8 | $99 |
Investigators on these documents
FEI number 3014498447 · most recent document Jul 15, 2021
About Inventive Infusion Solutions, LP
How many FDA Form 483s has Inventive Infusion Solutions, LP received?
FDA Intel has 1 Form 483 on file for Inventive Infusion Solutions, LP; the most recent is dated Aug 31, 2018.
When was Inventive Infusion Solutions, LP last inspected by FDA?
The most recent FDA inspection document on file for Inventive Infusion Solutions, LP is a Form 483 dated Aug 31, 2018, for the site in San Antonio, Texas.
What did FDA cite at Inventive Infusion Solutions, LP?
The regulations cited most in the observations on file for Inventive Infusion Solutions, LP are 21 CFR 211.113 (Control of microbiological contamination), 4 times; 21 CFR 211.42 (Design and construction features), 2 times; 21 CFR 211.167 (Special testing requirements), 1 time.
Has Inventive Infusion Solutions, LP received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Inventive Infusion Solutions, LP; the most recent is dated Jul 15, 2021.